Back close

Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases

Publication Type : Journal Article

Thematic Areas : Nanosciences and Molecular Medicine

Publisher : Expert Opinion on Drug Delivery, Taylor and Francis Ltd

Source : Expert Opinion on Drug Delivery, Taylor and Francis Ltd, Volume 13, Issue 8, p.1177-1194 (2016)

Url :

Campus : Kochi

School : School of Pharmacy, Center for Nanosciences

Center : Amrita Center for Nanosciences and Molecular Medicine Move, Nanosciences

Department : Nanosciences and Molecular Medicine, Pharmacology, Nanosciences

Year : 2016

Abstract : Introduction: Chitosan, a polymer from the chitin family has diverse pharmaceutical and bio-medical utility because of its easy widespread availability, non-toxicity, biocompatibility, biodegradability, rich functionalities and high drug-loading capacity. Recent pharmaceutical research has examined the use of chitosan-based systems for drug delivery applications in various diseases. The availability of functional groups permits the conjugation of specific ligands and thus helps to target loaded drugs to the site of infection/inflammation. Slow biodegradation of chitosan permits controlled and sustained release of loaded moieties; reduces the dosing frequency and is useful for improving patient compliance in infectious drug therapy. The muco-adhesion offered by chitosan makes it an attractive candidate for anti-inflammatory drug delivery, where rapid clearance of the active moiety due to the increased tissue permeability is the major problem. The pH-dependent swelling and drug release properties of chitosan present a means of passive targeting of active drug moieties to inflammatory sites. Areas covered: Development of chitosan-based nanoparticulate systems for drug delivery applications is reviewed. The current state of chitosan-based nanosystems; with particular emphasis on drug therapy in inflammatory and infectious diseases is also covered. Expert opinion: The authors believe that chitosan-based nanosystems, due to the special and specific advantages, will have a promising role in the management of infectious and inflammatory diseases. © 2016 Informa UK Limited, trading as Taylor amp; Francis Group

Cite this Research Publication : Rajitha Panonnummal, Gopinath, D., Dr. Raja Biswas, Dr. Sabitha M., and Dr. Jayakumar Rangasamy, “Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases”, Expert Opinion on Drug Delivery, vol. 13, no. 8, pp. 1177-1194, 2016

Admissions Apply Now